StockWatch
·
Pharmaceuticals
Board Meeting14 Oct 2026, 11:26 am

Lyka Labs Board Meeting on Oct 30 to Approve Q2 FY27 Results

AI Summary

Lyka Labs Ltd has announced that its Board of Directors will convene on October 30, 2026. The primary agenda item is to consider and approve the unaudited standalone and consolidated financial results for the second quarter and half-year ended September 30, 2026. The company will also present the Limited Review Report from its statutory auditor. The financial results will be made available on the company's website.

Key Highlights

  • Board meeting scheduled for October 30, 2026.
  • Approval of Q2 and H1 FY27 unaudited financial results.
  • Review of standalone and consolidated financial statements.
  • Limited Review Report from statutory auditor to be presented.